Insights

Biggest ASX losers in May could be winners in June

This month has been a particularly volatile period for ASX shares but some of the worst performers could see a…
The post Biggest ASX losers in May could be winners in June appeared first on The Motley Fool Australia. –

This month has been a particularly volatile period for ASX shares but some of the worst performers could see a rebound in June.

For one, risk appetite appears to be improving again in the last week or so. This means investors could be in a more forgiving mood as they hunt for bargains.

And what better place to look for value stocks than among ASX shares that have been punished for issuing bad news in May?

Returning to growth

Mind you, not all of May’s ASX sinners are worth a second glance. However, Goldman Sachs reckons the Costa Group Holdings Ltd (ASX: CGC) share price could be one to back.

The fruit and veggies grower is one of the worst performers on the S&P/ASX 200 Index (Index:^AXJO) for the month. Just about all of its losses came in the last two trading days when it warned that labour shortages and weak prices for some of its produce will weigh on its bottom line.

The update triggered a more than 20% crash in the Costa Group share price. But Goldman is urging investors to buy the stock now as it believes the sell-off is an overreaction.

Buy the dip

“The business is well positioned over the medium term. Expansion of international operations is the key growth driver in the business,” said the broker.

“We forecast China/Morocco to contribute 36% to Group EBITDA by FY23 (vs. 17% in CY19).”

Goldman reiterated its “buy” recommendation on the Costa Group share price with a 12-month price target of $4.85 a share.

Catching a breath

Another laggard with a bright medium-term outlook is the Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) share price. The medical device maker shed more than 13% in the past week and is down 18.4% in the month.

Earnings disappointment was the trigger for the sell-off but Goldman believes the mid to longer-term prospects remains positive.

Stronger earnings ahead

“Whilst we had factored a sequential slowdown to reflect the decline in hospitalisations, we had under-estimated the extent,” said Goldman.

“We re-base our consumables forecasts to reflect this lower exit-rate, driving -8-10% revisions to our FY22-25E sales forecasts. The other negative surprise to us today was that air freight costs appear set to remain elevated for some time (currently running at 2x ‘pre-pandemic’ levels).”

But the broker’s earnings before interest, tax, depreciation and amortisation (EBITDA) forecast for FY22 through FY25 are still 4% to 12% above COVID-19 levels.

Goldman is recommending the Fisher & Paykel share price as a “buy” with a price target of $33 a share.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of May 24th 2021

More reading

These were the best performing ASX 200 shares last week

These were the worst performing ASX 200 shares last week

ASX 200 surges to new record, Fortescue drops, Inghams flies higher

A2 Milk (ASX:A2M) shares are up 4% today. Has a bottom been found?
These 3 shares are this week’s biggest fallers of the ASX 200

The post Biggest ASX losers in May could be winners in June appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!